Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

FY26 FR0 DFS/PHL - Cepheid Norovirus, Mpox, Multiplex Reagent

Active

State & Local

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract pertains to the acquisition of testing supplies specifically for the Cepheid Norovirus, Mpox, and Multiplex reagents under the Fiscal Year 2026 forecast for the Department of Forensic Sciences in the District of Columbia. It is categorized as a forecast listing, indicating it is a planned procurement rather than an active solicitation, with no formal solicitation number assigned at this time. The primary focus is on reagents used in diagnostic testing to support forensic and public health laboratories, likely to enhance detection capabilities for infectious agents relevant to criminal investigations and community health monitoring. There is no designated set-aside type, NAICS code, or organizational type specified, and the agency details are limited to the Forensic Sciences division within the District of Columbia, with no明确 office address or place of performance provided. No point of contact information is listed, and the contract remains in a pre-solicitation phase, intended to inform potential vendors of upcoming procurement needs. The associated UI link provides access to the official forecast posting for further details as the procurement process advances.

General Info

Acquisition of Cepheid reagents for forensic and public health testing under FY2026 forecast.

Agency

District of Columbia → Forensic Sciences (DFS)

NAICS

325413 - In-Vitro Diagnostic Substance ManufacturingView NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 23

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDistrict of Columbia → Forensic Sciences (DFS)

ContactsNo contacts available

OfficeN/A

Organization / Agency

District of Columbia → Forensic Sciences (DFS)

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Testing Supplies

Similar Contracts

Same NAICS industry code

FY26 FR0 DFS/PHL - Roche Flu Surveillance Testing ReagentThe contract anticipates the procurement of testing reagents for influenza surveillance under the Forensic Sciences Division of the District of Columbia for fiscal year 2026. The initiative is part of a broader public health effort to monitor flu activity, with reagents intended for use in diagnostic and surveillance testing. While specific quantities, delivery timelines, or technical specifications are not detailed in the forecast, the reagents will support laboratory-based detection and analysis of influenza strains across the jurisdiction. This procurement is categorized as a forecast, indicating it is a planning tool for vendors to prepare for an upcoming solicitation, and no formal solicitation number has been issued as of the posting date. The agency responsible, DFS, is based in Washington D.C., and performance is expected to occur within the district, though no specific location is provided. Vendors interested in participating should monitor future official solicitations, as this forecast serves only as an early indicator of intent and does not constitute a binding request for proposals.

Forensic Sciences (DFS)

POSTED

about 2 hours ago

DEADLINE

FY26 FR0 DFS/PHL - Qiagen reagentsThe contract forecasts the procurement of Qiagen reagents for forensic science testing applications under the Fiscal Year 2026 budget cycle, managed by the Forensic Sciences division within the District of Columbia. This initiative is tied to laboratory operations requiring reliable molecular diagnostics reagents, likely supporting DNA analysis, sample preparation, or other forensic testing workflows essential to criminal investigations and evidence processing. While the solicitation number and procurement details are not yet available, the posting date indicates this is a future forecast with no set-aside provisions indicated, meaning the opportunity is open to all eligible vendors without geographic or size-based restrictions. The place of performance and organizational details remain unspecified, but the activity is centered within the District of Columbia’s forensic system, suggesting delivery and use will occur at state or local forensic laboratories. No point of contact information is provided at this stage, and the NAICS code, office address, and other typical contracting metadata are also absent, indicating this is an early-stage forecast meant for market research and vendor awareness. Interested suppliers should monitor the official DC contracting portal for future solicitations tied to this forecast, as detailed requirements, timelines, and ordering procedures will be released in subsequent procurement actions.

Forensic Sciences (DFS)

POSTED

about 2 hours ago

DEADLINE

FY26 FR0 DFS/PHL - IDT Sequencing ReagentThe contract forecast pertains to the procurement of sequencing reagents for the Forensic Sciences Division of the District of Columbia, scheduled for fiscal year 2026. The solicitation is intended to support forensic DNA analysis operations, with the reagents critical to maintaining the accuracy and efficiency of sequencing workflows used in criminal investigations and evidence processing. Despite the lack of specific solicitation numbers, NAICS codes, or set-aside details, the anticipated procurement reflects an ongoing operational need within the agency’s forensic laboratory capabilities. The place of performance and point of contact information are currently unspecified, suggesting the details are still under development or will be finalized closer to the formal solicitation release. The posting date indicates the forecast is publicly available to potential vendors as an early notification ahead of a future bid opportunity, allowing suppliers to prepare proposals and align their offerings with the agency’s requirements.

Forensic Sciences (DFS)

POSTED

about 2 hours ago

DEADLINE

FY26 FR0 DFS/PHL - Illumina AMD reagentsThe District of Columbia’s Forensic Sciences Division is forecasting procurement needs for AMD testing reagents in fiscal year 2026, with the solicitation posted on July 23, 2026. This forecast indicates an upcoming requirement for reagents used in forensic DNA analysis, likely supporting laboratory operations for criminal investigations and evidence processing. The contract is intended for Illumina-branded AMD reagents, suggesting a specific technology platform is preferred for genotyping or sequencing applications in the forensic context. Although the solicitation number, NAICS code, set-aside details, and office location are not yet specified, the procurement is being managed under the agency’s procurement portal and will likely proceed through a formal competitive process. Performance is expected to be delivered within the District of Columbia, aligning with the agency’s operational base. Interested vendors should monitor the official contract portal for the eventual release of a formal request for proposal, as this forecast serves as a preliminary notice to prepare for potential bidding opportunities.

Forensic Sciences (DFS)

POSTED

about 2 hours ago

DEADLINE

CALIBRATOR KIT, HAEMATOThe CALIBRATOR KIT, HAEMATOLOGY is a specialized reagent kit designed for calibrating UNICEL DXH COULTER cellular analysis systems used in hematology applications, with each unit containing 3.3 mL of calibrator. It is subject to strict technical and quality requirements as defined in the DLA Master List of Technical and Quality Requirements, and must comply with DLA packaging standards including the Medical Marking Standard No. 1, which supersedes MIL-STD-129. The item is classified as a Type I (Code A) shelf-life item with a non-extendable shelf life of one month, requiring that no more than four days pass between the date of manufacture and delivery to the government. All packaging must include the date of manufacture, expiration date, contract number, and lot number, in accordance with the latest revision of MMS1C. The calibrator must be stored and transported under refrigerated conditions between 2°C to 8°C (36°F to 46°F) and must not be frozen. Packaging must be commercial-grade, sealed, and designed to protect contents from damage during shipping, with exterior containers suitable for safe delivery via common carrier at the lowest cost. The product is associated with NSN 6550-01-625-1271 and is being procured under solicitation SPE2DS-26-T-262K, with a required delivery within five days after award, and bidders must clearly specify the source and part number being offered.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, CHLORIDE DThis contract is for the procurement of TEST KIT, CHLORIDE D, specifically CHLORIDE QUANTAB TEST STRIPS rated for a high range of 300 to 6000 mg/L, supplied in quantities of 40 strips per bottle, with one bottle required. The item is identified by NSN 6550-01-722-0245 and is subject to strict technical and quality standards referenced from the DLA Master List of Technical and Quality Requirements, which govern its specification and compliance. The product must meet commercial packaging requirements as defined for medical acquisitions, including sealed unit containers to prevent damage and shipping containers suitable for safe transport at the lowest carrier rate. All packaging and marking must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and include mandatory labeling with the date of manufacture, expiration date, and contract or lot number in accordance with MMS1C. The item has a non-extendable shelf life of 24 months, and no more than three months may have elapsed between the date of manufacture and delivery to the government. Delivery is required within 20 days after award, with performance addressed to Hampton, Virginia, under contract number SPE2DS-26-T-261X issued on July 22, 2026, with responses due by July 28, 2026. Bidders must provide the source and part number being offered, and the supply is subject to DLA packaging requirements and the potential application of covered defense information regulations. All items must be marked for government use and comply with procedures for removal of government identification from non-accepted supplies. The procurement is managed by the Department of Defense’s Medical Supply Chain under the office of Marc Canalichio, with full technical and logistical specifications enforced by DLA Troop Support.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

6640--LAB - ROCHE BENCHMARK ULTRA PLUS STAIN CPT

242-NETWORK Contract Office 02 (36C242)

POSTED

DEADLINE

Notice of Intent to Sole Source Serology DV-1-4 EDIII Reagents

Centers For Disease Control And Prevention

POSTED

DEADLINE

65--Special Notice of Intent to Sole Source AwardThe U.S. Fish and Wildlife Service intends to award a sole source firm fixed price contract to Qiagen, LLC for proprietary genetic reagents and consumables essential to the Pacific Region Fisheries and Aquatic Conservation Program and the Abernathy Fish Technology Center. The requirement, classified under NAICS code 325413, involves specialized patented products that are critical to maintaining the integrity of genetic analysis workflows and supporting federally mandated species recovery plans. Qiagen is the exclusive manufacturer and distributor of these items, with no authorized resellers, and previous attempts to use alternative suppliers have yielded unreliable results that compromise mission-critical research. The contract value is expected to be at or below the simplified acquisition threshold of $350,000, authorized under FAR Part 12.102(a). This notice serves solely as an intent to award and does not constitute a solicitation, but interested parties may submit a written statement of capabilities demonstrating how competition would benefit the government. All submissions must be sent via email as a Microsoft Word or Adobe PDF attachment to Lawrence_aragon@ios.doi.gov by August 1, 2026, and must provide clear and convincing evidence supporting competitive procurement. No telephone inquiries or offers will be accepted, and respondents bear full responsibility for any costs incurred in preparing their submissions. The contracting office is located in Falls Church, Virginia, with the point of contact being Lorenzo Aragon.

It Services Fws

POSTED

DEADLINE

TEST KIT, CORONAVIRUS DThe contract specifies the procurement of Abbott BinaxNOW COVID-19 Antigen Self Test kits for over-the-counter, at-home use, with each case containing twelve kits and each kit providing two tests. The test kits must be stored between 2 and 30 degrees Celsius and have a non-extendable shelf life of 12 months, with no more than one month elapsed from the date of manufacture to the date of delivery to the government. All packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and each unit must be sealed in a suitable container to protect against damage, with exterior shipping containers ensuring safe, cost-effective delivery to the specified FPO address. Labels must clearly indicate the date of manufacture, expiration date, and contract or lot number. Technical and quality requirements are governed by the DLA Master List, and the item is subject to applicable defense information and packaging standards. The procurement is under contract SPE2DS-26-T-255U with a single case ordered, a 20-day delivery timeline, and primary contact information provided for coordination.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, CHLAMYDIA TRAThis contract is for the procurement of a qualitative direct immunofluorescence test kit designed to detect Chlamydia trachomatis in human urogenital and ocular specimens, as well as to confirm the presence of Chlamydiae in cell cultures. The kit includes two positive control slides, mounting fluid, and the specific Chlamydia test reagent, ensuring accurate and reliable results for diagnostic purposes. The National Stock Number is 6550-01-725-3600, with a quantity of two kits requested under purchase request number 7017563729, and delivery is required within five days after order placement. The solicitation, identified as SPE2DS-26-T-257E, was posted on July 21, 2026, with a response deadline of July 27, 2026, and is categorized under NAICS code 325413 for pharmaceutical and medicine manufacturing. It is issued by the Department of Defense through the Medical Supply Chain MD Surg FSF, indicating federal procurement for military or veteran healthcare needs. The point of contact for inquiries is Mary-Kathryn Donahue, reachable via phone or email, and the contract is being managed through the DIBBS platform for government procurement activities.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TRICHROME STAINING SETThe TRICHROME STAINING SET is a histological reagent kit designed for tissue differentiation, containing 250 mL of Wheatley trichrome stain, three 250 mL bottles of 70% ethanol, 250 mL of acid ethanol 90%, two 250 mL bottles of 95% ethanol, two 250 mL bottles of xylene-S, and five 0.75 mL ampules of Lugol’s iodine. The product must be stored in its original container at room temperature and is sold as a single unit. It is classified as a TYPE I (CODE F) item with a strict non-extendable shelf life of six months, requiring that no more than three weeks have passed from the date of manufacture to the date of delivery to the government. All packaging and labeling must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and must include the date of manufacture, expiration or retest date, contract number, and lot number in accordance with MMS1C guidelines. The item must be packaged in sealed unit containers that protect against damage and shipped in commercial exterior containers suitable for safe delivery via common carrier at the lowest rate to the specified delivery point in Williamsburg, Virginia. The procurement is governed by DLA’s master list of technical and quality requirements, packaging standards, and removal protocols for government identification on non-accepted supplies, with the solicitation issued under contract number SPE2DS-26-T-258J and NSN 6550-01-710-7934, with a required delivery within five days of award.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE